Filter
1

Palbociclib & Tazemetostat

Recruiting
PHASE1

Sponsor:

Thomas Jefferson University

Location:

Philadelphia PA

Code:

NCT05627232

Conditions

Recurrent Acute Myeloid Leukemia

Refractory Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tazemetostat

Liposome-encapsulated Daunorubicin-Cytarabine

Bone Marrow Aspiration and Biopsy

Biospecimen Collection

Palbociclib

RZ358

Recruiting
PHASE3

Sponsor:

Rezolute

Location:

Philadelphia PA, Saskatoon

Code:

NCT06208215

Conditions

Congenital Hyperinsulinism

Eligibility Criteria

Sex: All

Age: 3 - 45

Healthy Volunteers: Not accepted

Interventions

RZ358 (5 mg/kg) + SOC (Standard-of-Care) or Placebo + SOC

RZ358 (10 mg/kg) or Placebo + SOC

RZ358 (5-10 mg/kg) + SOC

Low-level Red-light Therapy

Recruiting

Sponsor:

UCLA

Location:

San Francisco CA

Code:

NCT05606237

Conditions

Myopia

Eligibility Criteria

Sex: All

Age: 8 - 13

Healthy Volunteers: Accepted

Interventions

Low-level Red Light Therapy Device

CAR T-Cells

Recruiting
EARLY_PHASE1

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Location:

Chapel Hill NC

Code:

NCT05620342

Conditions

Lung Cancer

Small Cell Lung Carcinoma

Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

iC9.GD2.CAR.IL-15 T Infusion

Obinutuzumab & CC-99282

Recruiting
PHASE2

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT06108232

Conditions

Follicular Lymphoma

Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Obinutuzumab

CC-99282

Interested in new nct05620823 trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

Observational Study

Recruiting

Sponsor:

Thomas Jefferson University

Location:

Philadelphia PA

Code:

NCT05108233

Conditions

Malignant Head and Neck Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survey Administration

Revlimid & Rituximab

Recruiting
PHASE2

Sponsor:

Chronic Lymphocytic Leukemia Research Consortium

Location:

La Jolla CA, Boston MA, New Hyde Park NY, Houston TX

Code:

NCT00628238

Conditions

Chronic Lymphocytic Leukemia

CLL

Untreated

Front-line

First-Line

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide and Rituximab

Observational Study

Recruiting

Sponsor:

Ohio State University Comprehensive Cancer Center

Location:

Columbus OH

Code:

NCT06208202

Conditions

Abuse Tobacco

Exposure

Eligibility Criteria

Sex: All

Age: 21 - 29

Healthy Volunteers: Accepted

Interventions

Behavioral Intervention

Biospecimen Collection

Survey Administration

Alcohol & Health

Recruiting

Sponsor:

University of Washington

Location:

Seattle WA

Code:

NCT05620849

Conditions

Sexual Behavior

Alcohol Drinking

Condomless Sex

Eligibility Criteria

Sex: Female

Age: 18 - 24

Healthy Volunteers: Accepted

Interventions

Online program

Nutritional Supplement

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver

Code:

NCT05602324

Conditions

Severe Infection

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Interventions

Lauric Acid and Berberine